menu search

Cassava sciences: my bullish take on biomarkers and ctad data

Cassava Sciences' stock is highly disputed due to conflicting opinions on the science behind its drug candidate, but outside research supports its app...

October 30, 2023, 3:30 am

Cassava sciences: why market skepticism persists despite positive findings on simufilam

Cassava Sciences' Alzheimer's drug, simufilam, reduced cognitive decline by 38% in a small study, but t...

July 5, 2023, 3:05 pm

Why shares of cassava sciences are dropping wednesday

simufilam slowed cognitive decline by 38% compared to a placebo after six months for patients with mild...

July 5, 2023, 11:44 am

New publication highlights basic science supporting simufilam

Publication Reviews Certain Receptor-Protein Interactions. Provides Overview of Basic Science Supporting simuf...

June 12, 2023, 1:15 pm

Cassava (sava) up on progress with alzheimers disease study

Cassava (SAVA) made positive progress with simufilam, an oral drug treatment for Alzheimer's disease de...

May 30, 2023, 1:11 pm

Why shares of cassava sciences jumped this week

The company has a small pipeline. Cassava also released data showing that simufilam could be useful as ...

May 12, 2023, 4:39 pm

Insider richard barry is betting big on cassava (sava) stock

Cassava Sciences (NASDAQ: SAVA ) stock rose 11% overnight after director Richard Barry said he bought shares worth $2.3 million. The company is workin...

March 9, 2023, 9:35 am

Cassava sciences stock undervalued with its $124 price target?

Casava Sciences Inc (NASDAQ: SAVA) stock has been the topic of much controversy in its quest for FDA approval for its ...

January 31, 2023, 2:01 am

Cassava sciences' data once again misunderstood

Cassava Sciences' simufilam staved off cognitive decline in mild Alzheimer's disease. The market reacte...

January 27, 2023, 11:37 am

Anavex's blarcamesine and other disease modifying treatments for alzheimer's disease

Treatments such as Aricept and likely simufilam that inhibit the formation of the nitro-oxidant peroxyn...

September 7, 2022, 3:23 pm

Cassava sciences is a worthwhile bet to consider

FDA approval for simufilam and successful trials of a new blood test to detect Alzheimer's disease coul...

April 25, 2022, 3:11 pm

Anavex's blarcamesine and cassava sciences' simufilam: the stabilization period for alzheimer's disease

Aricept and blarcamesine limit further oxidative stress in Alzheimer's disease via agonism of Sigma-1 receptors. ...

March 22, 2022, 10:16 pm

Does cassava sciences and its alzheimer's drug really have what it takes?

Can Cassava Sciences' simufilam drug really treat Alzheimer's? Who really knows....

February 8, 2022, 5:30 pm

Does cassava sciences and its alzheimer's drug really have what it takes?

Can Cassava Sciences' simufilam drug really treat Alzheimer's? Who really knows....

February 8, 2022, 5:30 pm

Does cassava sciences and its alzheimer's drug really have what it takes?

Can Cassava Sciences' simufilam drug really treat Alzheimer's? Who really knows....

February 8, 2022, 5:30 pm

Cassava sciences starts late-stage simufilam study in alzheimer's patients

Cassava Sciences Inc (NASDAQ: SAVA) initiated an initial Phase 3 efficacy study of simufilam, an inv...

October 6, 2021, 12:31 pm

Cassava sciences starts late-stage simufilam study in alzheimer's patients

Cassava Sciences Inc (NASDAQ: SAVA) initiated an initial Phase 3 efficacy study of simufilam, an inv...

October 6, 2021, 12:31 pm

Cassava sciences starts late-stage simufilam study in alzheimer's patients

Cassava Sciences Inc (NASDAQ: SAVA) initiated an initial Phase 3 efficacy study of simufilam, an inv...

October 6, 2021, 12:31 pm


Search within

Pages Search Results: